Loading stock data...

Add-Shop E-Retail Limited

BSE: ASRL

BSE
10.65 0.43 (4.21%)

Prev Close

10.22

Open Price

10.54

Volume

9,822

Today Low / High

10.5 / 10.68

52 WK Low / High

7.62 / 15.9

Range

10 - 11

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 10.65, reflecting a change of 0.43 (4.20744%). The expected target range on the BSE is 10 - 11. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

24 Apr 10.54 1.04%
23 Apr 10.69 -4.40%
22 Apr 10.40 2.79%
21 Apr 10.45 1.63%
17 Apr 10.38 0.67%
16 Apr 10.70 -2.99%
15 Apr 10.32 1.65%
11 Apr 11.16 -4.84%
09 Apr 11.32 -3.36%
08 Apr 9.60 17.92%
07 Apr 9.22 3.80%
04 Apr 10.99 -0.73%
03 Apr 9.40 9.47%
02 Apr 9.80 -5.20%
01 Apr 7.76 17.91%
28 Mar 7.94 -3.15%
27 Mar 8.70 -8.39%

Add-Shop E-Retail Limited Graph

Add-Shop E-Retail Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Add-Shop E-Retail Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 10.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 10.65 10.76 9.68 - 11.83
10.86 8.69 - 13.04
10.97 7.68 - 14.26
Bearish Scenario 10.65 10.54 9.49 - 11.60
10.44 8.35 - 12.52
10.33 7.23 - 13.43

Overview of Add-Shop E-Retail Limited

ISIN

INE01B501018

Industry

Medical - Pharmaceuticals

Vol.Avg

71,170

Market Cap

301,533,450

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for ASRL

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 202.08 Cr 179.68 Cr 22.41 Cr 0.1109 0.00 Cr 0.50 Cr 7.76 Cr 3.16 Cr 1.12 7.59 Cr 0.0156
2023-03-31 197.33 Cr 152.97 Cr 44.37 Cr 0.2248 0.00 Cr 0.00 Cr 30.87 Cr 19.16 Cr 7.86 31.41 Cr 0.0971
2022-03-31 159.65 Cr 120.80 Cr 38.85 Cr 0.2434 0.00 Cr 0.00 Cr 24.70 Cr 19.09 Cr 7.76 25.16 Cr 0.1196
2021-03-31 78.57 Cr 56.53 Cr 22.04 Cr 0.2805 0.00 Cr 0.00 Cr 11.28 Cr 7.68 Cr 3.12 11.48 Cr 0.0977
2020-03-31 37.34 Cr 25.41 Cr 11.93 Cr 0.3196 0.00 Cr 0.00 Cr 2.41 Cr 1.20 Cr 0.49 2.64 Cr 0.0322

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 0.00 Cr 125.95 Cr 15.92 Cr 110.0337 Cr 12.20 Cr 12.20 Cr 25.79 Cr 6.09 Cr 0.00 Cr 0.00 Cr 5.00 Cr 15.0616 Cr
2023-03-31 0.43 Cr 150.85 Cr 43.97 Cr 106.8765 Cr 0.98 Cr 0.55 Cr 28.07 Cr 6.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 42.9570 Cr
2022-03-31 1.09 Cr 50.70 Cr 11.31 Cr 39.3889 Cr 3.30 Cr 2.21 Cr 19.47 Cr 6.99 Cr 0.03 Cr 0.00 Cr 0.04 Cr 7.8631 Cr
2021-03-31 0.52 Cr 44.84 Cr 24.53 Cr 20.3020 Cr 9.08 Cr 8.56 Cr 7.83 Cr 4.68 Cr 0.13 Cr 0.00 Cr 0.03 Cr 22.0390 Cr
2020-03-31 0.26 Cr 33.22 Cr 20.59 Cr 12.6253 Cr 7.44 Cr 7.18 Cr 7.12 Cr 3.53 Cr 0.01 Cr 0.00 Cr 0.00 Cr 18.8311 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 -29.6847 Cr 18.6083 Cr 11.7921 Cr -29.7986 Cr 0.7157 Cr 1.1491 Cr -0.1139 Cr 3.1571 Cr 0.0000 Cr 0.0000 Cr 2.2810 Cr
2023-03-31 -45.7448 Cr -0.9185 Cr 46.0035 Cr -46.6633 Cr -0.6598 Cr 0.4334 Cr -0.9185 Cr 19.1625 Cr -2.3217 Cr 0.0000 Cr -8.6033 Cr
2022-03-31 7.7152 Cr -2.7837 Cr -4.3551 Cr 4.9315 Cr 0.5764 Cr 1.0932 Cr -2.7837 Cr 19.0868 Cr 0.0000 Cr 0.0000 Cr -11.6342 Cr
2021-03-31 -0.4041 Cr -1.4241 Cr 2.0839 Cr -1.8282 Cr 0.2557 Cr 0.5168 Cr -1.4241 Cr 7.6767 Cr 0.0000 Cr 0.0000 Cr -0.7119 Cr
2020-03-31 -3.2951 Cr -0.4898 Cr 3.8040 Cr -3.7999 Cr 0.0190 Cr 0.2611 Cr -0.5048 Cr 1.2038 Cr 0.0000 Cr 0.0000 Cr -1.7075 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 33.83 Cr 24.35 Cr 9.48 Cr 0.2802 1.53 Cr 0.92 Cr 0.32 1.67 Cr 0.0272
2024-09-30 31.20 Cr 23.25 Cr 7.96 Cr 0.2550 1.49 Cr 0.88 Cr 0.31 1.63 Cr 0.0284
2024-06-30 40.36 Cr 33.05 Cr 7.31 Cr 0.1811 1.95 Cr 1.15 Cr 0.41 2.09 Cr 0.0285
2024-03-31 58.38 Cr 62.28 Cr -3.90 Cr -0.0667 -9.70 Cr -6.99 Cr -2.47 -9.60 Cr -0.1197
2023-12-31 56.99 Cr 46.34 Cr 10.65 Cr 0.1869 4.27 Cr 2.52 Cr 0.89 4.41 Cr 0.0443

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 0.74 Cr 0.00 Cr 0.74 Cr 103.28 Cr 31.27 Cr 136.16 Cr 6.05 Cr 143.31 Cr 31.24 Cr
2024-03-31 1.15 Cr 0.00 Cr 1.15 Cr 86.74 Cr 25.79 Cr 113.73 Cr 6.09 Cr 125.95 Cr 15.92 Cr
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 1.19 Cr 0.00 Cr 1.19 Cr 94.50 Cr 33.06 Cr 128.94 Cr 6.29 Cr 136.10 Cr 21.60 Cr
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 2.52 Cr 0.28 Cr 0.00 Cr 0.00 Cr 0.28 Cr 1.47 Cr 1.19 Cr 0.00 Cr 0.28 Cr
2023-09-30 2.35 Cr 2.35 Cr 0.00 Cr 0.00 Cr 2.35 Cr 1.19 Cr -1.15 Cr 0.00 Cr 2.35 Cr
2023-06-30 5.27 Cr 5.27 Cr 0.00 Cr 0.00 Cr 4.84 Cr 5.27 Cr 0.43 Cr 0.00 Cr 5.27 Cr
2023-03-31 2.46 Cr 2.46 Cr 0.00 Cr 0.00 Cr 2.46 Cr 0.43 Cr -2.03 Cr 0.00 Cr 2.46 Cr
2022-12-31 4.71 Cr 4.71 Cr 0.00 Cr 0.00 Cr -20.14 Cr 4.71 Cr 24.84 Cr 0.00 Cr 4.71 Cr

Splits History

Date Label Split Ratio
2022-08-05 August 05, 22 1277:1000
2022-01-14 January 14, 22 17:10
2020-07-22 July 22, 20 7:4

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹820.60 ₹98,220,756,898.00 ₹85,846.00

Key Executives

Chief Financial Officer
Mr. Rajen Pratapbhai Vyas

Gender: male

Year Born: 1981

Executive Director
Ms. Maharshi Jigar Pandya

Gender: female

Year Born: 1997

Company Secretary & Compliance Officer
Ms. Vinita Thadani

Gender: female

Year Born:

Executive Director
Ms. Jayshreeben Dineshbhai Pandya

Gender: female

Year Born: 1972

Executive Director
Ms. Shraddha Dev Pandya

Gender: female

Year Born: 1994

MD & Director
Mr. Dineshbhai Bhanushankar Pandya

Gender: male

Year Born: 1973

FAQs about Add-Shop E-Retail Limited

Who is the CEO of the company?

The CEO is Mr. Dineshbhai Bhanushankar Pandya.

What is the current market price of the stock?

The current price is ₹10.65.

What is the 52-week price range?

The range is ₹7.62-15.9.

What is the market capitalization of the company?

The market capitalization is ₹30.15 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -7.59.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Add-Shop E-Retail Limited (ISIN: INE01B501018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹30.15 crores and an average daily volume of 71,170 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack